Shorts
0:16
Why Individualized Care Matters in the Age of "Preventative Botox"
a month ago
by
Shawna Jones, PA-C
0:36
Expanding Access and Promoting Purpose in Dermatology
a month ago
by
Amy Snow, PA-C
0:39
How to Stop Patients from Following Unsafe Skin Care Trends
a month ago
by
Suneel Chilukuri, M.D.
Why Patients May Not Be Taking Your Skin Care Advice
2 months ago
by
Rivkah Epstein, PA-C
0:41
Could Improving Gut Health Also Improve Rosacea Symptoms?
2 months ago
by
Rajani Katta, MD(+1 more)
1:30
Why Food Testing Often Fails for Atopic Dermatitis
2 months ago
by
Renata Block, DMSc, MMS, PA-C(+1 more)
0:45
26 Million People Gain Access to Innovative Skin Therapy
3 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)
1:09
A Message to the Next Generation of Dermatology Clinicians
3 months ago
by
Henry W. Lim, MD
1:00
Empowering PAs and NPs Through Journal Clubs
4 months ago
by
Dylan Timmermann, PA-C
1:00
The Emotional Toll of Misdiagnosis
5 months ago
by
Renata Block, DMSc, MMS, PA-C(+1 more)
Podcasts
Continuing Medical Education
All News
Advertisement
Genetic MR links gut microbiome shifts to eczema, dermatitis, rosacea and more, spotlighting cytokines like IL‑10, IL‑18 and IL‑6 as therapeutic targets.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on granulomatous dermatoses during dupilumab therapy, SAAD-41 validation in alopecia, updated vitiligo trends, and more.
This review of the latest dermatological studies includes insights into vitiligo, including emerging surgical techniques, the impact of social media, camouflage agents, and more.
Career decisions in dermatology are too often driven by emotion rather than data, according to a new practice management column examining common pitfalls in contract evaluation and compensation negotiations.
Two clinic cases illustrate why dermatologic providers must apply broad general medicine training in every encounter.
The 3-phase Isoclear regimen pairs topical isotretinoin with clindamycin, tranexamic acid, niacinamide, and copper peptide based on treatment stage.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on a mobile AI platform for skin disease prescreening, COVID-19 outcomes in PsO patients on biologics, i-PRF) and laser therapy for facial rejuvenation, and more.
Advertisement
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on PeakPASI in psoriasis severity, the future of digital derm lectures, negative pressure wound therapy, and more.
Turn Therapeutics is preparing to request an FDA meeting to discuss regulatory strategy and potential pathways toward market following successful Phase 2 completion.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Employment contracts can have enormous financial and career consequences, yet many clinicians review them too casually before signing.
This review of the latest dermatological studies includes insights on methylsulfonylmethane in dermatology, the use of ultrasound in cutaneous mastocytoma, AI-augmented morphometric reporting for aesthetic treatments, and more.
Clinical outcomes improved in both switch directions following treatment modification, with substantial reductions in PASI and EASI scores.
Evidence and experience together reinforce that extended leave can restore psychological well-being and professional sustainability.
Strong clinical observation and knowledge of disease variants are essential when advanced diagnostics are unavailable.
This review of the latest dermatological studies includes insights on familial HS comorbidities, localized HA acne patch therapy, profiles of dyshidrotic eczema patients, and more.
Resource-poor environments exist not only globally but also in everyday settings like nursing homes, prisons, foster care, and low-income households.
Researchers reported that patients with more extensive HS disease involvement experienced significantly greater financial strain.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on cross-linked HA for neck wrinkles, dupilumab for eczema molluscatum, 10 ms pulsed dye laser for rosacea, and more.
Listening to favorite music or white noise during cosmetic botulinum toxin injections eases pain and stress, especially for first-time patients, with simple, low-cost comfort benefits.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
In this episode, Renata Block, DMSc, MMS, PA-C, and Zachary Rubin, MD, discuss the overlapping worlds of allergy and dermatology—and how better cross-specialty understanding can dramatically improve patient outcomes.
This review of the latest dermatological studies includes insights on social media and DTC pediatric alopecia treatments, BTX-A and Profhilo combination therapy, diagnostic barriers in dermatomyositis, and more.
About one-quarter of acne-related genetic variants also contribute to IBD risk.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
In the pivotal trials, dupilumab significantly reduced itch severity and urticaria activity at week 24 and increased rates of well-controlled disease and complete response compared with placebo.
This review of the latest dermatological studies includes insights on Vitamin B12's connection to hyperpigmentation, treatment modalities for female pattern hair loss, 0.5% timolol maleate eye drops for rosacea, and more.
A new survey reveals the significant disconnect between dermocosmetic labeling and clinical reality. Explore more and vote in today's poll.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Affecting up to 25% of children worldwide, pediatric AD carries a significant quality of life burden that extends to caregivers.
The biologic is the first of its kind approved for young children with antihistamine-refractory CSU, expanding an existing indication that previously covered adults and adolescents.
This review of the latest dermatological studies includes insights on minoxidil in onychodystrophy, teleheath outcomes in HS patients, pediatric AD referrals, and more.
AI-analyzed EHRs show a surging burden of hidradenitis suppurativa, chronic urticaria, psoriasis, and eczema, with major comorbidities, costly care, and low biologic use.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Emerging acne therapies like narrow-spectrum antibiotics, hormonal agents, and immunomodulators are promising, more personalized alternatives to isotretinoin, according to new research.
Patients who are needle-averse may soon have effective non-injectable options with biologic-like results.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Offers must pair strong compensation with operational and cultural support to succeed.
Successful negotiation integrates compensation, productivity, procedural access, and autonomy to create a sustainable, well-valued clinical role.
Renata Block, DMSc, MMS, PA-C, and Jamie Restivo, MPAS, PA-C, explore how hypochlorous acid sprays and sodium hypochlorite washes simplify AD adjunct care, improving adherence, antimicrobial control, and symptom relief.
Clinician contract negotiation is often treated as administrative, but it directly affects pay, autonomy, workflow, and career trajectory.
Omar Noor, MD, FAAD, discusses strategies to improve psoriasis care for patients facing adherence challenges related to lifestyle or cognitive barriers.
Trainees identified legal, ethical, and reliability concerns as key barriers to integrating AI into dermatology practice.
Women often present with sudden skin, hair, and vascular changes that may signal perimenopause rather than normal aging.
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, reviewed clinical trial and long-term data supporting biologic therapies for HS, emphasizing individualized patient selection and timing of intervention.
New top-line results from the BE BOLD trial provide dermatology clinicians with comparative data on 2 biologic therapies targeting different inflammatory pathways in psoriatic arthritis (PsA).
Jessica DeLuise, PA-C, MHS, CCMS, joins Derm Dispatch to discuss how nutrition and lifestyle intersect with inflammatory skin disease across clinical settings.
Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed clinical cases highlighting the distinct roles of topical ruxolitinib, tapinarof, and roflumilast in managing itch, inflammation, and long-term disease control in atopic dermatitis.
Douglas DiRuggiero, DMSc, MHS, PA-C, emphasized that relying solely on body surface area underestimates psoriasis burden, particularly for patients with disease in high-impact or special areas.
Real-world data show IL-17 biologics rapidly improve special-site psoriasis and quality of life, as researchers identified predictors of PASI75/90 response.
Explore PDPA’s 2025 compensation survey, revealing dermatology PA salary trends, workload patterns, benefits insights, and job satisfaction across the state of Pennsylvania.
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, highlighted that CHE is often mischaracterized and frequently involves overlapping subtypes.
Omar Noor, MD, shares pearls on type 2 inflammation, including dupilumab insights for atopic dermatitis, prurigo nodularis, and CSU at Horizons in Advanced Practice.
Baker explains why competency-based autonomy and structured collaboration are essential in high-acuity medical dermatology.
Dermatology Times recently concluded its second annual Horizons in Advanced Practice meeting in Tampa, Florida, featuring nurse practitioners and physician assistants from across the country.
HS is frequently misdiagnosed for 7 to 10 years because its symptoms resemble conditions like inflamed epidermal cysts, nodulocystic acne, and furuncles.
In the latest Cutaneous Connection podcast episode, Renata Block, DMSc, MMS, PA-C, and patient advocate Suki Tipp discuss the clinical, emotional, and financial toll of delayed diagnosis of indolent systemic mastocytosis.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
PDPA’s 2025 survey, led by president Jamie Restivo, PA-C, reveals dermatology PA pay trends, productivity bonuses, benefits gaps, and satisfaction drivers shaping retention.
The new hub for dermatology NPs and PAs offers education, community, and resources to enhance patient care and professional growth.
Patient education and partner involvement significantly enhance melanoma detection, especially in underserved and skin-of-color populations, improving survival outcomes.
Discover essential career insights for early-career NP/PAs in dermatology, focusing on skill mastery, mentorship, and professional growth strategies.
Recludix Pharma has initiated clinical trials for REX-8756, a promising oral STAT6 inhibitor targeting inflammatory diseases, marking a significant milestone in treatment innovation.
At the Dermatology Times Horizons in Advanced Practice meeting in Tampa, Florida, conference chair Lakshi Aldredge, MSN, ANP-BC, DCNP, focused a discussion on efficacy data for adalimumab, secukinumab, and bimekizumab.
Izabela Horzempa, PA-C, analyzes the challenges of chronic hand eczema (CHE) and shares innovative treatment options that enhance patient quality of life and management strategies.
Read on to catch up on all of the episodes of Derm Dispatch from this year.
Discover how NPs and PAs shaped the future of dermatology this year as leaders inspire the next generation to thrive in their careers.
Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed the 3 latest non-steroidal topicals for atopic dermatitis at the Horizons in Advanced Practice meeting.
Lakshi Aldredge, MSN, ANP-BC, DCNP, discussed key symptoms of CHE, the function of the JAK-STAT pathway, and key data from the DELTA trials evaluating delgocitinib cream at the Horizons in Advanced Practice meeting.
Discover the latest advancements in dermatology from the 2025 Elevate-Derm Fall Conference held in Tampa, Florida.
Maui Derm NP+PA Fall 2025 conference showcases cutting-edge insights in dermatology, featuring expert discussions on skin cancer, atopic dermatitis, and rare dermatoses.
Stacey Swinehart, DNP, FNP-BC, DCNP, CNL, shares key takeaways for clinicians from the SDNP's recent webinar on detecting intimate partner violence among patients.
Douglas DiRuggiero receives the prestigious Stead Silver Ford Honorary Award, celebrating his dedication and impact in dermatology and medical education.
Matthew Brunner, MHS, PA-C, discusses upcoming highlights of the 6th annual meeting for dermatology NPs and PAs.
The exclusive event brought together physician assistants and nurse practitioners from across the country to review complex atopic dermatitis, psoriasis, chronic hand eczema, and hidradenitis suppurativa patient cases.
Explore the latest advancements and expert insights from the SDPA Fall 2025 Meeting held in San Antonio, Texas.
What exciting sessions and updates are you looking forward to at the SDPA Fall 2025 Conference in San Antonio? Click here to answer our poll and let us know!
Preview the SDPA Fall 2025 conference in San Antonio for 4 days of networking, education, and expert-led sessions for dermatology PAs.
New data presented at Fall Clinical 2025 reveal that patients in socioeconomically disadvantaged areas are significantly less likely to initiate biologic or small molecule treatments.
Jamie Restivo, MPAS, PA-C, shares her key takeaways from the first day of the recent Pennsylvania Dermatology Physician Assistants (PDPA) Keystone Dermatology Conference in Philadelphia, Pennsylvania.
Advertisement
Advertisement
Trending on Dermatology Times
1
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Phase 2 Trial Supports Oral VDPHL01 for Female Pattern Hair Loss
4
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
5